Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 60 points (0.4%) at 16,517 as of Tuesday, April 1, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,859 issues advancing vs. 1,154 declining with 141 unchanged. The Financial sector currently sits up 0.1% versus the S&P 500, which is up 0.4%. Top gainers within the sector include ING Groep N.V ( ING), up 2.8%, Blackstone Group ( BX), up 2.1%, Deutsche Bank ( DB), up 2.1%, UBS ( UBS), up 2.0% and Equifax ( EFX), up 2.0%. On the negative front, top decliners within the sector include PartnerRe ( PRE), down 3.2%, NASDAQ OMX Group ( NDAQ), down 3.0%, Cincinnati Financial Corporation ( CINF), down 2.4%, CME Group ( CME), down 1.4% and Health Care REIT ( HCN), down 1.0%. TheStreet would like to highlight 3 stocks pushing the sector higher today: 3. MetLife ( MET) is one of the companies pushing the Financial sector higher today. As of noon trading, MetLife is up $0.48 (0.9%) to $53.28 on average volume. Thus far, 3.1 million shares of MetLife exchanged hands as compared to its average daily volume of 5.8 million shares. The stock has ranged in price between $53.21-$54.43 after having opened the day at $54.18 as compared to the previous trading day's close of $52.80. MetLife, Inc., through its subsidiaries, provides insurance, annuities, and employee benefit programs in the United States, Japan, Latin America, Asia, Europe, and the Middle East. MetLife has a market cap of $59.2 billion and is part of the insurance industry. Shares are down 2.1% year-to-date as of the close of trading on Monday. Currently there are 14 analysts who rate MetLife a buy, no analysts rate it a sell, and 2 rate it a hold. TheStreet Ratings rates MetLife as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, good cash flow from operations, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full MetLife Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.